Emergent BioSolutions Canada Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 155 Innovation Drive, Winnipeg, Manitoba R3T5Y3, Canada (CAN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003153579 · DUNS 203508049
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2019-09-13
- VAIBlood and Blood Products2017-05-16
- VAIDrug Quality Assurance2015-02-03
- VAIBlood and Blood Products2014-07-18
- VAIBlood and Blood Products2012-06-21
- VAIDrug Quality Assurance2011-10-19
- VAIBlood and Blood Products2010-04-22
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- raxibacumabEmergent Manufacturing Operations Baltimore LLC
- Vaccinia Immune Globulin Intravenous (Human)Emergent BioSolutions Canada Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.